SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-24-025263
Filing Date
2024-03-22
Accepted
2024-03-22 21:30:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea0202287-13dkidron_oramed.htm SC 13D 42932
  Complete submission text file 0001213900-24-025263.txt   44454
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79895 | Film No.: 24776738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 142 W. 57TH ST. NEW YORK NY 10019
Business Address
KIDRON NADAV (Filed by) CIK: 0001351779 (see all company filings)

Type: SC 13D